Unique DUOX2+ACE2+ small cholangiocytes are pathogenic targets for primary biliary cholangitis
2023 · Nature Communications · 56 citations
https://doi.org/10.1038/s41467-022-34606-w
J
Jintao Xiao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
199
Citations
5
h-index
4
i10-index
Jintao Xiao is an academic researcher from Central South University. The author has contributed to research in topics: Pediatric Hepatobiliary Diseases and Treatments & Inflammatory Bowel Disease & Mesenchymal stem cell research. The author has an h-index of 5, co-authored 6 publications.
ORCID: 0000-0002-4072-7816Papers by this author
works<i>Clostridium Scindens</i> Protects Against Vancomycin‐Induced Cholestasis and Liver Fibrosis by Activating Intestinal FXR‐FGF15/19 Signaling
2024 · Advanced Science · 8 citations
https://doi.org/10.1002/advs.202406445
524 CLOSTRIDIUM SCINDENS PROTECTS AGAINST CHOLESTATIC LIVER DISEASE THROUGH FXR-FGF15/19-TCA AXIS
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)04017-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat